Streetbeat News

Earnings

AMS

American Shared Hospital (AMEX:AMS) is scheduled to release its quarterly earnings report on March 27, 2024. Analysts predict an EPS of $0.02. The company's past performance shows mixed results with both positive and negative price changes post-earnings announcement. Shares are currently trading at $2.585, reflecting a 9.03% decrease over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

GREE

Greenidge Generation Holdings (NASDAQ:GREE) is scheduled to release its quarterly earnings report on March 27, 2024. Analysts predict an EPS of $0.25. The company's past earnings performance shows a mix of misses and beats, with the last quarter missing EPS estimates by $0.95 but resulting in a 2.32% share price increase the following day. Over the last year, GREE's shares have decreased by 14.82%, indicating potential concern among long-term shareholders ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

TNP

Tsakos Energy Navigation (NYSE:TNP) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $1.71. The company's past earnings performance shows a mix of hits and misses against estimates, with the stock price reacting accordingly. Shares have risen 32.11% over the last 52 weeks, indicating a positive outlook from long-term shareholders ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

REE

REE Automotive (NASDAQ:REE) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-2.38. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. REE's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 5.75% drop. Over the last year, REE's stock has declined by 39.41%, indicating potential concern among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

DTIL

Precision BioSciences (NASDAQ:DTIL) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-2.05. The company's past earnings performance shows a history of beating EPS estimates, which has occasionally led to positive stock price movements the following day. However, the stock has experienced a 44.55% decline over the last 52 weeks. Investors are looking for not just an earnings beat but also positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:01 pm

GAIA

Gaia, Inc. (NASDAQ:GAIA) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.02. Investors are hopeful for a beat on this estimate and positive guidance for future growth. Gaia's stock performance has shown a 5.42% increase over the last 52 weeks, with shares trading at $2.91 as of March 25. Historical earnings performance and stock price reactions indicate a potential positive impact on the stock price if Gaia beats earnings estimates and provides optimistic future guidance.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm

CLRB

Cellectar Biosciences (NASDAQ:CLRB) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.59. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss leading to a 2.42% drop. Shares have risen 180.94% over the last 52 weeks, indicating a positive long-term outlook. Investors will be keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm

GMDA

Gamida Cell (NASDAQ:GMDA) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-0.15. Analysts and investors will be looking for the company to beat this estimate and provide positive guidance for future growth. Historical data shows mixed reactions in stock price to past earnings performances, with a notable 55.95% decline in share value over the last 52 weeks. The upcoming earnings report is crucial for investor sentiment, especially considering the stock's recent performance.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 5:00 pm

AAPL

VGT

XLK

Apple Inc (NASDAQ:AAPL) has seen a significant decline in iPhone shipments in China, with a 33% drop in February year-over-year, following a 39% reduction in January. This downturn is attributed to rising competition, particularly from Huawei Technologies Co, and a broader slowdown in China's smartphone market. Despite this, Apple plans to launch its Vision Pro headset in China by 2024. The company's stock has gained 8% over the last 12 months, and exposure to AAPL can be gained through ETFs like Vanguard Information Tech ETF (NYSE:VGT) and SPDR Select Sector Fund - Technology (NYSE:XLK).

Portfolio Pulse from Anusuya Lahiri

March 26, 2024 | 4:58 pm

PRAX

Praxis Precision Medicines Inc (NASDAQ:PRAX) reported positive results from its Phase 2a study of PRAX-628 for epilepsy, showing strong response rates and good tolerability. The company plans to begin a focal epilepsy efficacy study in the second half of 2024. PRAX-628 demonstrated efficacy in preclinical and Phase 1 studies, with dose-dependent exposure and a significant pharmacodynamic effect. Shares of PRAX surged 15.40% to $58.29.

Portfolio Pulse from Vandana Singh

March 26, 2024 | 4:54 pm